For children with cancer, where they live too often determines their chance of survival.
The Bristol Myers Squibb Foundation recently launched Global HOPE (Hematology-Oncology Pediatric Excellence), a program that aims to improve the health outcomes of children with cancer living in southern and east Africa.
Together with the Texas Children's Cancer and Hematology Centers and Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children's Hospital, the Bristol Myers Squibb Foundation this week announced a combined $100 million grant to build and operate an innovative pediatric hematology-oncology treatment network that will help provide long-term capacity to treat and dramatically improve the prognosis of thousands of children in the region.